OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION (Page 2 of 2)

Warnings

For external use only

Do not use on damaged or broken skin

Stop use and ask a doctor if rash occurs

When using this product keep out of eyes. Rinse with water to remove.

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

• apply liberally 15 minutes before sun exposure
• use a water resistant sunscreen if swimming or sweating
• reapply at least every 2 hours
• children under 6 months: Ask a doctor
• Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including:
  • limit time in the sun, especially from 10 a.m.–2 p.m.
  • wear long-sleeved shirts, pants, hats, and sunglasses

Inactive ingredients

1,2-hexanediol, caprylyl glycol, ceteareth-20, cetearyl alcohol, chlorphenesin, citric acid, cyclopentasiloxane, dimethicone, dimethicone crosspolymer-3, disodium EDTA, glycerin, hydrogenated palm glycerides, hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, methylisothiazolinone, PEG-40 stearate, pentylene glycol, phenoxyethanol, phenyl trimethicone, polysilicone-11, polysorbate 60, potassium sorbate, sodium benzoate, sodium dihydroxycetyl phosphate, sodium polyacrylate, squalane, stearyl alcohol, tetrahexyldecyl ascorbate, tropolone, water, xanthan gum

Other information

• store at controlled room temperature: 15°C–25°C (59°F–77°F)
• protect this product from excessive heat and direct sun

Questions or comments?

1.800.636.7546
Monday–Friday 9 a.m.–4 p.m. Pacific Time

Store at controlled room temperature 15°C–25°C (59°F–77°F).

Obagi-C and the Obagi logo are registered trademarks of OMP, Inc.

Distributed by OMP, Inc., Long Beach, CA 90806

©2012 Obagi Medical Products, Inc. All rights reserved.
obagi.com Made in USA 41502211Z 5022

PRINCIPAL DISPLAY PANEL — Kit Carton

NDC# 62032-524-04

OBAGI^®
MEDICAL

OBAGI-C^® RX SYSTEM

NORMAL DRY
Skin Intervention Kit

Established Pharmacological Class

Substance Pharmacological Class OBAGI-C RX SYSTEM C-CLEANSINGWITH VITAMIN C Cleansing (cold creams, cleansing lotions, liquids, and pads) OBAGI-C RX SYSTEM C-EXFOLIATING DAYWITH VITAMIN C Face and Neck (excluding shaving preparations)

OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION hydroquinone, octinoxate and zinc oxide kit

Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:62032-524

Packaging # Item Code Package Description Multilevel Packaging 1 NDC:62032-524-04 1 KIT in 1 CARTON None

Quantity of Parts Part # Package Quantity Total Product Quantity Part 1 1 BOTTLE, GLASS 30 mL Part 2 1 BOTTLE, PLASTIC 57 g Part 3 1 TUBE 85 g Part 4 1 BOTTLE, PLASTIC 177 mL Part 5 1 BOTTLE, PLASTIC 57 g

Part 1 of 5 OBAGI-C RX SYSTEM C-CLARIFYING SERUM SKIN LIGHTENING SERUM WITH VITAMIN C hydroquinone liquid

Product Information Item Code (Source) NDC:62032-106 Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength HYDROQUINONE (HYDROQUINONE) HYDROQUINONE 40 mg in 1 mL

Inactive Ingredients Ingredient Name Strength PROPYLENE GLYCOL WATER ASCORBIC ACID SODIUM LAURYL SULFATE PROPYLENE CARBONATE

Packaging # Item Code Package Description Multilevel Packaging 1 NDC:62032-106-10 1 BOTTLE, GLASS in 1 CARTON contains a BOTTLE, GLASS 1 30 mL in 1 BOTTLE, GLASS This package is contained within the CARTON (62032-106-10)

Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date Unapproved drug other 01/01/2004

Part 2 of 5 OBAGI-C RX SYSTEM C-THERAPY SKIN LIGHTENING WITH VITAMINS C AND E hydroquinone cream

Product Information Item Code (Source) NDC:62032-105 Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength HYDROQUINONE (HYDROQUINONE) HYDROQUINONE 40 mg in 1 g

Inactive Ingredients Ingredient Name Strength EDETATE DISODIUM PPG-2 MYRISTYL ETHER PROPIONATE TROLAMINE SALICYLATE SODIUM LAURYL SULFATE CETYL ALCOHOL GLYCERIN LACTIC ACID .ALPHA.-TOCOPHEROL ACETATE ASCORBIC ACID SODIUM METABISULFITE WATER METHYLPARABEN PROPYLPARABEN BUTYLATED HYDROXYTOLUENE PHENYL TRIMETHICONE

Product Characteristics Color WHITE Score Shape Size Flavor Imprint Code Contains

Packaging # Item Code Package Description Multilevel Packaging 1 NDC:62032-105-36 57 g in 1 BOTTLE, PLASTIC None

Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date Unapproved drug other 01/01/2004

Part 3 of 5 OBAGI-C RX SYSTEM SUN SHIELD BROAD SPECTRUM SPF 50 MATTE SUNSCREEN octinoxate and zinc oxide lotion

Product Information Item Code (Source) NDC:62032-121 Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength OCTINOXATE (OCTINOXATE) OCTINOXATE 75 mg in 1 g ZINC OXIDE (ZINC OXIDE) ZINC OXIDE 105 mg in 1 g

Inactive Ingredients Ingredient Name Strength GLYCERIN PHENOXYETHANOL CYCLOMETHICONE 5 WATER PEG-10 DIMETHICONE (600 CST) PENTYLENE GLYCOL STEARYL ALCOHOL POLYOXYL 20 CETOSTEARYL ETHER PHENYL TRIMETHICONE PEG-40 STEARATE DIMETHICONE SODIUM DIHYDROXYCETYL PHOSPHATE HYDROGENATED PALM GLYCERIDES CITRIC ACID MONOHYDRATE CETOSTEARYL ALCOHOL .ALPHA.-TOCOPHEROL ACETATE 1,2-HEXANEDIOL CAPRYLYL GLYCOL TROPOLONE CHLORPHENESIN XANTHAN GUM POTASSIUM SORBATE SODIUM BENZOATE TETRAHEXYLDECYL ASCORBATE UBIDECARENONE EDETATE DISODIUM METHYLISOTHIAZOLINONE HYDROXYETHYL ACRYLATE/SODIUM ACRYLOYLDIMETHYL TAURATE COPOLYMER (45000 MPA.S AT 1%) SQUALANE POLYSORBATE 60 SODIUM POLYACRYLATE (2500000 MW)

Product Characteristics Color WHITE Score Shape Size Flavor Imprint Code Contains

Packaging # Item Code Package Description Multilevel Packaging 1 NDC:62032-121-90 85 g in 1 TUBE None

Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC monograph final part352 02/21/2013

Part 4 of 5 OBAGI-C RX SYSTEM C-CLEANSING WITH VITAMIN C inert gel

Product Information Route of Administration TOPICAL DEA Schedule

Ingredients Ingredient Name Quantity WATER GLYCERIN PHENOXYETHANOL ETHYLPARABEN ISOBUTYLPARABEN BUTYLPARABEN PROPYLPARABEN METHYLPARABEN ASCORBIC ACID SODIUM LAUROYL OAT AMINO ACIDS COCAMIDOPROPYL BETAINE SODIUM LAURETH-3 SULFATE ALOE VERA LEAF SODIUM CHLORIDE ALFALFA CHAMOMILE XANTHAN GUM D&C RED NO. 33 FD&C YELLOW NO. 5

Product Characteristics Color ORANGE Score Shape Size Flavor Imprint Code Contains

Packaging # Item Code Package Description Multilevel Packaging 1 177 mL in 1 BOTTLE, PLASTIC None

Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date Cosmetic 01/01/2004

Part 5 of 5 OBAGI-C RX SYSTEM C-EXFOLIATING DAY WITH VITAMIN C inert lotion

Product Information Route of Administration TOPICAL DEA Schedule

Ingredients Ingredient Name Quantity WATER GLYCERIN PHENOXYETHANOL ETHYLPARABEN ISOBUTYLPARABEN BUTYLPARABEN PROPYLPARABEN METHYLPARABEN POLYSORBATE 60 GLYCERYL MONOSTEARATE PEG-100 STEARATE ETHYLHEXYL PALMITATE SQUALANE HYDROXYETHYL ACRYLATE/SODIUM ACRYLOYLDIMETHYL TAURATE COPOLYMER (45000 MPA.S AT 1%) PEG-8 DIMETHICONE PEG-8 RICINOLEATE GLYCOLIC ACID ARGININE ETHYLHEXYL STEARATE MEDIUM-CHAIN TRIGLYCERIDES ISOPROPYL PALMITATE HYALURONATE SODIUM SODIUM HYDROXIDE CETOSTEARYL ALCOHOL POLYOXYL 20 CETOSTEARYL ETHER DIMETHICONE STEARETH-2 ASCORBYL GLUCOSIDE LEVOMENOL EDETATE SODIUM .ALPHA.-TOCOPHEROL ACETATE

Product Characteristics Color WHITE Score Shape Size Flavor Imprint Code Contains

Packaging # Item Code Package Description Multilevel Packaging 1 57 g in 1 BOTTLE, PLASTIC None

Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date Cosmetic 01/01/2004

Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date Unapproved drug other 04/02/2013

Labeler — OMP, INC. (790553353)

Establishment
Name	Address	ID/FEI	Operations
PURETEK CORPORATION		785961046	MANUFACTURE (62032-524), LABEL (62032-524), PACK (62032-524)

Establishment
Name	Address	ID/FEI	Operations
Ei INC.		105803274	MANUFACTURE (62032-524), LABEL (62032-524), PACK (62032-524), ANALYSIS (62032-524)

Establishment
Name	Address	ID/FEI	Operations
MILBAR LABORATORIES		195556790	MANUFACTURE (62032-524)

Establishment
Name	Address	ID/FEI	Operations
Bay Cities Container Corporation		066229618	RELABEL (62032-524), REPACK (62032-524)

Revised: 08/2013 OMP, INC.